These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2550412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.
    Bonaros NE, Kocher A, Dunkler D, Grimm M, Zuckermann A, Ankersmit J, Ehrlich M, Wolner E, Laufer G.
    Transplantation; 2004 Mar 27; 77(6):890-7. PubMed ID: 15077033
    [Abstract] [Full Text] [Related]

  • 3. The importance of cytomegalovirus in heart-lung transplant recipients.
    Hutter JA, Scott J, Wreghitt T, Higenbottam T, Wallwork J.
    Chest; 1989 Mar 27; 95(3):627-31. PubMed ID: 2537711
    [Abstract] [Full Text] [Related]

  • 4. Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients.
    Wreghitt TG, Abel SJ, McNeil K, Parameshwar J, Stewart S, Cary N, Sharples L, Large S, Wallwork J.
    Transpl Int; 1999 Mar 27; 12(4):254-60. PubMed ID: 10460870
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus infections in heart and heart and lung transplant recipients.
    Wreghitt TG, Hakim M, Gray JJ, Kucia S, Wallwork J, English TA.
    J Clin Pathol; 1988 Jun 27; 41(6):660-7. PubMed ID: 2838530
    [Abstract] [Full Text] [Related]

  • 7. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
    Icenogle TB, Peterson E, Ray G, Minnich L, Copeland JG.
    J Heart Transplant; 1987 Jun 27; 6(4):199-203. PubMed ID: 2822880
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB.
    Pediatr Infect Dis J; 1988 May 27; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone.
    Valantine HA, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, Robbins R, Berry G, Reitz B.
    Transplantation; 2001 Nov 27; 72(10):1647-52. PubMed ID: 11726825
    [Abstract] [Full Text] [Related]

  • 12. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.
    Kaplan CS, Petersen EA, Icenogle TB, Copeland JG, Villar HV, Sampliner R, Minnich L, Ray CG.
    Arch Intern Med; 1989 Sep 27; 149(9):2095-100. PubMed ID: 2549896
    [Abstract] [Full Text] [Related]

  • 13. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
    Vrtovec B, Thomas CD, Radovancevic R, Frazier OH, Radovancevic B.
    J Heart Lung Transplant; 2004 Apr 27; 23(4):461-5. PubMed ID: 15063406
    [Abstract] [Full Text] [Related]

  • 14. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM, Grinnan DC, Diane Reams B, Steele MP, Messier RH, Duane Davis R.
    Clin Transplant; 2004 Apr 27; 18(2):179-85. PubMed ID: 15016133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients.
    Nicol DL, MacDonald AS, Belitsky P, Lee S, Cohen AD, Bitter-Suermann H, Lowen J, Whalen A.
    Transplantation; 1993 Apr 27; 55(4):841-6. PubMed ID: 8386404
    [Abstract] [Full Text] [Related]

  • 18. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
    Zamora MR, Fullerton DA, Campbell DN, Leone S, Diercks MJ, Fisher JH, Badesch DB, Grover FL.
    Transplant Proc; 1994 Oct 27; 26(5 Suppl 1):49-51. PubMed ID: 7940974
    [Abstract] [Full Text] [Related]

  • 19. CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
    Schulz U, Solidoro P, Müller V, Szabo A, Gottlieb J, Wilkens H, Enseleit F.
    Transplantation; 2016 Mar 27; 100 Suppl 3(Suppl 3):S5-10. PubMed ID: 26900992
    [Abstract] [Full Text] [Related]

  • 20. Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants.
    Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG.
    J Infect Dis; 1992 Mar 27; 165(3):548-52. PubMed ID: 1311352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.